|
US2016199449A1
|
|
Method of reducing antigenic drift or reassortment of viruses in a host animal using alpha interferon
|
|
WO2015010022A2
|
|
Method of diagnosing and stabilizing cfs/me symptoms in a candidate patient
|
|
AU2013206335A1
|
|
dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
|
|
US2010160413A1
|
|
Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
|
|
AU2009308105A1
|
|
Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
|
|
AU2009215128A1
|
|
Selective agonist of toll-like receptor 3
|
|
CA2715294A1
|
|
Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species
|
|
AU2008266910A1
|
|
Early intervention of viral infections with immune activators
|
|
US5683986A
|
|
Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
|
|
US5593973A
|
|
Treatment of viral hepatitis with mismatched dsRNA
|
